Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
WuXi PharmaTech plans to continue its growth by expanding...
Merck, Lilly and Pfizer will work together to compile a...
WuXi PharmaTech (药明康德) has struck a two-way...
IMS Health predicts China’s drug market will see a...
As expected, WuXi PharmaTech (药明康德) reported 2009...
AutekBio raised $100 million to build Asia’s...
In a blockbuster announcement, Charles River Laboratories...
WuXi PharmaTech (药明康德), continuing the string of...
WuXi PharmaTech (药明康德) reported Q1 revenues rose...
Beijing Yu Sheng Tang Pharma signed a MoU to purchase 70%...
Upcoming Events
BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here
Register here
Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events
Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here